Shanghai Henlius Biotech’s Privatization by Fosun New Medicine

Freshfields Bruckhaus Deringer (‘Freshfields’) advised Shanghai Henlius Biotech, Inc. on its proposed privatisation.Shanghai Henlius Biotech, Inc. (‘Henlius’), a biopharmaceutical company listed on the Hong Kong Stock…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here
Avatar

Author: Georgio Naffaa

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here